Indinavir
- Generic Name
- Indinavir
- Brand Names
- Crixivan
- Drug Type
- Small Molecule
- Chemical Formula
- C36H47N5O4
- CAS Number
- 150378-17-9
- Unique Ingredient Identifier
- 9MG78X43ZT
- Background
A potent and specific HIV protease inhibitor that appears to have good oral bioavailability. [PubChem]
- Indication
Indinavir is an antiretroviral drug for the treatment of HIV infection.
- Associated Conditions
- Human Immunodeficiency Virus Type 1 (HIV-1) Infection
- Associated Therapies
- -
A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-10-29
- Target Recruit Count
- 800
- Registration Number
- NCT00000914
- Locations
- 🇺🇸
North Jersey Community Research Initiative, Newark, New Jersey, United States
🇺🇸Community Consortium / UCSF, San Francisco, California, United States
🇺🇸AIDS Research Consortium of Atlanta, Atlanta, Georgia, United States
A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-10-29
- Target Recruit Count
- 24
- Registration Number
- NCT00000896
- Locations
- 🇺🇸
Ucsd, Avrc Crs, San Diego, California, United States
🇺🇸University of Colorado Hospital CRS, Aurora, Colorado, United States
🇺🇸Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis, Indiana, United States
The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-10-29
- Target Recruit Count
- 108
- Registration Number
- NCT00000850
- Locations
- 🇺🇸
UCLA CARE Ctr, Los Angeles, California, United States
🇺🇸Marin County Specialty Clinic, San Rafael, California, United States
🇺🇸Rush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, United States
A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas
- Conditions
- Ewing's SarcomaRhabdomyosarcoma
- Interventions
- Biological: therapeutic autologous dendritic cellsDrug: indinavir sulfateProcedure: peripheral blood stem cell transplantation
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2012-06-15
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 42
- Registration Number
- NCT00001566
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection
- Conditions
- HIV Infection
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2017-07-02
- Target Recruit Count
- 42
- Registration Number
- NCT00001644
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.